Senzime was awarded a CE Mark for its OnZurf probe, a tool for gastrointestinal tract surgical procedures.
Here's what you should know:
1. Senzime will now launch the probe throughout Europe. Senzime will sell the probe directly in Scandinavia and is in the process of establishing distribution agreements with the rest of Europe.
2. The probe is unique because it allows physicians to continuously collect samples from an organ's surface.
3. Physicians can place the probe on a tissue or organs' surface to monitor local metabolic changes. The probe also monitors a patient's healing process after surgery, alerting physicians to possible postoperative complications.
Senzime AB CEO Lena Söderström said, "Continuous sampling in patients undergoing surgery may provide an opportunity to detect early complications. The clinical market seeks products that allow continuous sampling and monitoring of tissue substances to detect complications after surgery and control interventions."